1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupport Opportunity for Addiction Research (SOAR) is sponsored by National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA). This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-DA-09-013: Notice of Intent to Publish a Request for Applications for Support Opportunity for Addiction Research (SOAR) for New Investigators Notice of Intent to Publish a Request for Applications for Support Opportunity for Addiction Research (SOAR) for New Investigators Notice Number: NOT-DA-09-013 Release Date: September 4, 2009 National Institute on Drug Abuse (NIDA), ( http://www. nida. nih.
gov ) National Institute on Alcohol Abuse and Alcoholism (NIAAA) ( http://www. niaaa. nih.
gov ) The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) intend to publish a Request for Applications (RFA) to solicit research applications under an initiative entitled “Support Opportunity for Addiction Research (SOAR) for New Investigators (R03).
” The purpose of this Funding Opportunity Announcement (FOA) is to support new investigator’s on-going basic or clinical alcohol, drug abuse and/or related co-morbidity research.
The primary goal of this Support Opportunity for Addiction Research (SOAR) is for new investigators to leverage existing research programs in order to strengthen, possibly expand, and/or further develop alcohol, drug abuse, and co-morbidity research. The FOA is expected to be published on or before December 2009 with an expected receipt date in April 2010. This FOA will utilize the NIH Small Research Grant Program (Parent R03).
This notice is being provided to allow potential applicants sufficient time to develop responsive projects. APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Interested parties may contact: Division of Neuroscience and Behavior National Institute on Alcohol Abuse and Alcoholism National Institutes of Health 5635 Fishers Lane, Room 2061 Division of Basic Neuroscience & Behavioral Research National Institute on Drug Abuse 6001 Executive Boulevard Rm 4282, MSC 9555 E-mail: [email protected] Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: State governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, For-profit organizations other than small businesses, Public housing authorities/Indian housing authorit…. Confirm the full requirements in the official notice before applying.
The current listing shows $1,200,000 estimated total program funding. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Support Opportunity for Addiction Research (SOAR) is funded by National Institute on Drug Abuse (NIDA) and National Institute on Alcohol Abuse and Alcoholism (NIAAA). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The HEAL Initiative's Studies to Enable Analgesic Discovery award (RFA-NS-25-023) puts federal money exactly where private capital won't go — the assay-building, screening, and hit-characterization stage of non-opioid pain therapeutics. It's a phased R61/R33, up to $350,000 in direct costs per year, with the next application deadline September 17, 2026. Here is how the two-phase structure works, who's eligible, and how to build a proposal that survives the R61-to-R33 milestone gate.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read articleARPA-H PROSPR program funds seven research teams testing rapamycin, semaglutide, and novel compounds to extend healthspan. A deep analysis of the science, the money, and what it means for the field.
Read article